9-2648747-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2

The NM_003383.5(VLDLR):​c.2041C>T​(p.Leu681Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0079 in 1,614,162 control chromosomes in the GnomAD database, including 98 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L681L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0055 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0082 ( 93 hom. )

Consequence

VLDLR
NM_003383.5 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: 2.68

Publications

9 publications found
Variant links:
Genes affected
VLDLR (HGNC:12698): (very low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene. [provided by RefSeq, Aug 2009]
VLDLR Gene-Disease associations (from GenCC):
  • cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • cerebellar ataxia, intellectual disability, and dysequilibrium
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.22).
BP6
Variant 9-2648747-C-T is Benign according to our data. Variant chr9-2648747-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 130706.
BP7
Synonymous conserved (PhyloP=2.68 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00546 (831/152290) while in subpopulation SAS AF = 0.0139 (67/4816). AF 95% confidence interval is 0.0112. There are 5 homozygotes in GnomAd4. There are 395 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VLDLRNM_003383.5 linkc.2041C>T p.Leu681Leu synonymous_variant Exon 14 of 19 ENST00000382100.8 NP_003374.3 P98155-1
VLDLRNM_001018056.3 linkc.2041C>T p.Leu681Leu synonymous_variant Exon 14 of 18 NP_001018066.1 P98155-2Q5VVF5
VLDLRNM_001322225.2 linkc.1918C>T p.Leu640Leu synonymous_variant Exon 13 of 18 NP_001309154.1 A0A7P0T897
VLDLRNM_001322226.2 linkc.1918C>T p.Leu640Leu synonymous_variant Exon 13 of 17 NP_001309155.1 A0A7P0T9P7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VLDLRENST00000382100.8 linkc.2041C>T p.Leu681Leu synonymous_variant Exon 14 of 19 1 NM_003383.5 ENSP00000371532.2 P98155-1

Frequencies

GnomAD3 genomes
AF:
0.00547
AC:
832
AN:
152172
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.00606
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0141
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00870
Gnomad OTH
AF:
0.00813
GnomAD2 exomes
AF:
0.00693
AC:
1741
AN:
251352
AF XY:
0.00795
show subpopulations
Gnomad AFR exome
AF:
0.00135
Gnomad AMR exome
AF:
0.00376
Gnomad ASJ exome
AF:
0.00477
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00139
Gnomad NFE exome
AF:
0.00881
Gnomad OTH exome
AF:
0.00881
GnomAD4 exome
AF:
0.00815
AC:
11921
AN:
1461872
Hom.:
93
Cov.:
32
AF XY:
0.00848
AC XY:
6164
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.00122
AC:
41
AN:
33480
American (AMR)
AF:
0.00414
AC:
185
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00444
AC:
116
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.0164
AC:
1415
AN:
86258
European-Finnish (FIN)
AF:
0.00212
AC:
113
AN:
53420
Middle Eastern (MID)
AF:
0.0160
AC:
92
AN:
5766
European-Non Finnish (NFE)
AF:
0.00860
AC:
9564
AN:
1111996
Other (OTH)
AF:
0.00652
AC:
394
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
719
1438
2158
2877
3596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
374
748
1122
1496
1870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00546
AC:
831
AN:
152290
Hom.:
5
Cov.:
32
AF XY:
0.00530
AC XY:
395
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00113
AC:
47
AN:
41554
American (AMR)
AF:
0.00372
AC:
57
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00606
AC:
21
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.0139
AC:
67
AN:
4816
European-Finnish (FIN)
AF:
0.00198
AC:
21
AN:
10618
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00870
AC:
592
AN:
68028
Other (OTH)
AF:
0.00804
AC:
17
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
42
84
126
168
210
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00706
Hom.:
5
Bravo
AF:
0.00547
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.0107
EpiControl
AF:
0.00948

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
Jan 27, 2014
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 29, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jun 15, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

VLDLR: BP4, BS1, BS2 -

Congenital cerebellar hypoplasia Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

VLDLR-related disorder Benign:1
May 01, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.22
CADD
Benign
8.6
DANN
Benign
0.79
PhyloP100
2.7
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79720897; hg19: chr9-2648747; API